# Rebuttal letter on behalf of all authors in response to the Letter to the Editor

**Authors:** Marwan Noel Sabbagh

PMC · DOI: 10.1016/j.tjpad.2025.100136 · 2025-04-11

## Full-text entities

- **Diseases:** Alzheimer's disease (MESH:D000544)
- **Chemicals:** lecanemab (MESH:C000612089), blarcamesine (MESH:C568535)

---
Source: https://tomesphere.com/paper/PMC12183970